Lista de obras - Alexey Larionov - Dominio Público Uruguay

A standard curve based method for relative real time PCR data processing

artículo científico publicado en 2005

Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione

artículo científico publicado en 1998

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

artículo científico publicado en 2015

Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears

artículo científico publicado en 2002

Aromatase in breast cancer tissue ? localization and relationship with reproductive status of patients

artículo científico publicado en 1996

Aromatase in skeletal muscle.

artículo científico publicado en 2003

Aromatase inhibitors--gene discovery

artículo científico

Aromatase inhibitors: cellular and molecular effects

artículo científico publicado en 2005

Bridging the gap between translational research and clinical application

scientific article published on 01 January 2011

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target.

artículo científico publicado en 2008

Challenges in defining predictive markers for response to endocrine therapy in breast cancer

artículo científico publicado en 2009

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

artículo científico

Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole

artículo científico publicado en 2010

Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients.

artículo científico publicado en 2018

Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis

artículo científico publicado en 2012

Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole

artículo científico

Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.

artículo científico publicado en 2018

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia

artículo científico publicado en 2011

High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.

artículo científico publicado en 2014

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

artículo científico publicado en 2015

Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues

artículo científico publicado en 2002

Malta (MYH9 Associated Elastin Aggregation) Syndrome: Germline Variants in MYH9 Cause Rare Sweat Duct Proliferations and Irregular Elastin Aggregations

artículo científico publicado en 2019

Molecular Changes in Lobular Breast Cancers in Response to Endocrine Therapy

artículo científico publicado en 2014

Molecular effects of oestrogen deprivation in breast cancer

scientific article published on 13 May 2011

Molecular response to aromatase inhibitor treatment in primary breast cancer

artículo científico publicado en 2007

Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects.

artículo científico publicado en 2002

Personalization of loco-regional care for primary breast cancer patients (part 1).

artículo científico publicado en 2015

Personalization of loco-regional care for primary breast cancer patients (part 2).

artículo científico publicado en 2015

Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors

artículo científico publicado en 2008

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

artículo científico publicado en 2009

Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole.

artículo científico publicado en 2010

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

artículo científico publicado en 2010

Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours

artículo científico publicado en 2005

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers

artículo científico publicado en 2016

Understanding the mechanisms of aromatase inhibitor resistance

artículo científico publicado en 2012

Use of microarray analysis to investigate EMT gene signatures

artículo científico publicado en 2013

Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation

scientific article published on 01 March 2013

Lista de obras de Alexey Larionov

A standard curve based method for relative real time PCR data processing

Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears

Aromatase in breast cancer tissue ? localization and relationship with reproductive status of patients

Aromatase in skeletal muscle.

Aromatase inhibitors--gene discovery

Aromatase inhibitors: cellular and molecular effects

Bridging the gap between translational research and clinical application

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target.

Challenges in defining predictive markers for response to endocrine therapy in breast cancer

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole

Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients.

Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis

Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole

Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia

High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues

Malta (MYH9 Associated Elastin Aggregation) Syndrome: Germline Variants in MYH9 Cause Rare Sweat Duct Proliferations and Irregular Elastin Aggregations

Molecular Changes in Lobular Breast Cancers in Response to Endocrine Therapy

Molecular effects of oestrogen deprivation in breast cancer

Molecular response to aromatase inhibitor treatment in primary breast cancer

Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects.

Personalization of loco-regional care for primary breast cancer patients (part 1).

Personalization of loco-regional care for primary breast cancer patients (part 2).

Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole.

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers

Understanding the mechanisms of aromatase inhibitor resistance

Use of microarray analysis to investigate EMT gene signatures

Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation